{
  "id": 16595526,
  "title": "Healthtech startup BioStack raises $9.5M in seed funding round led by Peak XV, others",
  "url": "https://urgent.news/2026/10/26/healthtech-startup-biostack-raises-9-5m-in-seed-funding-round-led-by",
  "topic": "business",
  "section": "Business",
  "published": "2026-10-26T11:31:37.000Z",
  "source": {
    "name": "YourStory",
    "slug": "yourstory",
    "url": "https://yourstory.com/2026/10/healthtech-startup-biostack-raises-seed-funding-led-by-peak-xv"
  },
  "original_language": "en",
  "account": "Healthtech startup BioStack has announced the successful completion of a $9.5 million seed funding round, spearheaded by Peak XV. Additional investors in the round included Afore Capital, DCVC, Emerson Collective, SV Angel, Verdict Capital, Streamlined Ventures, and Y Combinator. The funding will facilitate BioStack's expansion across the United States and international markets, bolster the development of its technology platform, and augment its engineering and research teams.\n\nThe company is also set to launch a data infrastructure network that will enable the next phase of medical advancements across the US, India, Brazil, and Argentina. This network will provide access to over 100 million de-identified patient records, allowing BioStack to build comprehensive workflows that integrate clinical information spanning disparate health systems and geographical locations. These workflows aim to offer a holistic view of patients, facilitating both immediate clinical decision-making and long-term research and artificial intelligence development.\n\nSanat Mishra, Co-founder and CEO of BioStack, elaborated on the significance of collecting and connecting every event related to each patient, stating, \"Collecting every event linked to each patient enables a view of what happens at each stage of a patient's journey. We're building the infrastructure that connects all of the clinical information and makes it useful, both for clinicians making decisions today and for the researchers and AI developers building the future of medicine.\"\n\nMoreover, BioStack generates proprietary datasets from the de-identified patient data it collects from each provider system. This data amalgamates biological and clinical information with treatment histories and long-term outcomes, enabling researchers to gain deeper insights into disease progression and treatment responses. The startup has already combined fragmented X-rays, MRIs, CT scans, and over several million telehealth audio transcripts with other pathology and clinical records, creating a robust dataset for training AI agents to assist clinicians in evaluating treatment options and predicting patient outcomes.\n\nCurrently operating in the US, Brazil, India, and Argentina, BioStack's reach spans a diverse patient population and healthcare environments, further solidifying its position as a leader in the healthtech sector.",
  "summary": "BioStack creates workflows that bring together clinical information across disparate health systems and geographies. It currently works with hospitals across the US, Brazil, India and Argentina.",
  "key_points": [
    "BioStack raises $9.5M seed funding from Peak XV and others",
    "Launches data infrastructure network for US, India, Brazil, Argentina",
    "Creates proprietary datasets for AI-assisted clinical decision-making"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}